Title : The soluble epoxide hydrolase inhibitor GSK2256294 decreases the proportion of adipose pro-inflammatory T cells - Mashayekhi_2021_Prostaglandins.Other.Lipid.Mediat_158_106604 |
Author(s) : Mashayekhi M , Wanjalla CN , Warren CM , Simmons JD , Ghoshal K , Pilkinton M , Bailin SS , Gabriel CL , Pozzi A , Koethe JR , Brown NJ , Kalams SA , Luther JM |
Ref : Prostaglandins Other Lipid Mediat , 158 :106604 , 2021 |
Abstract : Mashayekhi_2021_Prostaglandins.Other.Lipid.Mediat_158_106604 |
ESTHER : Mashayekhi_2021_Prostaglandins.Other.Lipid.Mediat_158_106604 |
PubMedSearch : Mashayekhi_2021_Prostaglandins.Other.Lipid.Mediat_158_106604 |
PubMedID: 34922004 |
Mashayekhi M, Wanjalla CN, Warren CM, Simmons JD, Ghoshal K, Pilkinton M, Bailin SS, Gabriel CL, Pozzi A, Koethe JR, Brown NJ, Kalams SA, Luther JM (2021)
The soluble epoxide hydrolase inhibitor GSK2256294 decreases the proportion of adipose pro-inflammatory T cells
Prostaglandins Other Lipid Mediat
158 :106604
Mashayekhi M, Wanjalla CN, Warren CM, Simmons JD, Ghoshal K, Pilkinton M, Bailin SS, Gabriel CL, Pozzi A, Koethe JR, Brown NJ, Kalams SA, Luther JM (2021)
Prostaglandins Other Lipid Mediat
158 :106604